arrow
T

Tina Vilsbøll

iqvia
H指数:87
被引数:3.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Living with a transplanted liver is associated with diabetes

与移植肝脏相关的糖尿病

2026-04-270
OAAI
Selenium supplementation in individuals with newly diagnosed Graves' hyperthyroidism: a double-blind, multi-centre RCT

新诊断的格雷夫斯氏甲亢患者中硒补充剂的应用:一项双盲、多中心随机对照试验

2026-01-011
PRE
Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1-based therapies: An expert consensus statement using a modified Delphi approach

Sievenpiper, J.L.; Ard, J.; Blüher, M.; Chen, W.; Dixon, J.B.; Fitch, A.; Gigliotti, L.; Khunti, K.; Lecube, A.; Lean, M.E.J.; 等. GLP-1基 therapies 管理肥胖的营养和生活方式支持性护理建议:一项采用改良德尔菲法的专家共识声明. Obes. Pillars 2026, 17, 100228. [Google Scholar] [CrossRef]

2025-12-011
OAAI
Using glucagon receptor antagonism to evaluate the physiological effects of extrapancreatic glucagon in totally pancreatectomised individuals: a randomised controlled trial

使用胰高血糖素受体拮抗作用来评估完全胰腺切除个体中胰腺外胰高血糖素的生理效应:一项随机对照试验

2025-09-180
OAAI
Once Weekly Utreglutide (GL0034), a Glucagon-like Peptide-1 Receptor Agonist, at 4 x 450 μg Doses Reduces Blood Pressure, Lipids, and Body Weight in Post-menopausal Females: A Phase I Study

每周一次注射的Utreglutide(GL0034),一种胰高血糖素样肽-1受体激动剂,在4×450 μg剂量的情况下,可降低绝经后女性的血压、血脂和体重:一项I期研究

2024-11-120
PRE
The role of glucagon-like peptide 1 in the postprandial effects of metformin in type 2 diabetes: a randomized crossover trial

胰高血糖素样肽1在2型糖尿病患者服用二甲双胍后餐后效应中的作用:一项随机交叉试验

2024-07-250
PRE
Glucagon Clearance Is Decreased in Chronic Kidney Disease but Preserved in Liver Cirrhosis

胰高血糖素清除率在慢性肾病中降低,但在肝硬化中得以保留

2024-07-250
PRE